ZDF
Sign inSign up

Vulnerabilities

Vulnerability · CVE-2025-13918

Symantec Endpoint Protection, prior to 14.3 RU10 Patch 1, RU9 Patch 2, and RU8 Patch 3, may be susceptible to a Elevation of Privilege vulnerability, which is a type of issue where

Published Jan 28, 2026 · catalog updated Feb 26, 2026 · Broadcom Symantec Endpoint Protection Windows Client

Last checked Nov 4, 2026. A connected source was read within the last 7 days.

Check if you run it

No confirmed exploitation is on record for CVE-2025-13918. EPSS is 0.16%. Act only if a listed version of Broadcom Symantec Endpoint Protection Windows Client is installed.

Gaps on this record

  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
Medium6.7
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.16%
Remediation
Advisory link
Affected products
vendor Broadcom Symantec Endpoint Protection Windows Client 14.3.12154.10000

Symantec Endpoint Protection, prior to 14.3 RU10 Patch 1, RU9 Patch 2, and RU8 Patch 3, may be susceptible to a Elevation of Privilege vulnerability, which is a type of issue whereby an attacker may attempt to compromise the software application to gain elevated access to resources that are normally protected from an application or user.

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • vendor Broadcom Symantec Endpoint Protection Windows Client 14.3.12154.1000014.3.12154.10000

How to fix CVE-2025-13918

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2025-13918. EPSS is 0.16%. Act only if a listed version of Broadcom Symantec Endpoint Protection Windows Client is installed.

Which versions are affected?

Compare what you have installed with Broadcom Symantec Endpoint Protection Windows Client 14.3.12154.10000 14.3.12154.10000. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

No weakness class is stored. EPSS 0.16%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Technology hubs

Windows security

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. Jan 28, 2026 · EUVD

    Detected

    Symantec Endpoint Protection, prior to 14.3 RU10 Patch 1, RU9 Patch 2, and RU8 Patch 3, may be susceptible to a Elevation of Privilege vulnerability, which is a type of issue whereby an attacker may attempt to compromise the software application to gain elevated access to resources that are normally protected from an application or user.

  2. Feb 26, 2026 · EUVD

    Updated

    Symantec Endpoint Protection, prior to 14.3 RU10 Patch 1, RU9 Patch 2, and RU8 Patch 3, may be susceptible to a Elevation of Privilege vulnerability, which is a type of issue whereby an attacker may attempt to compromise the software application to gain elevated access to resources that are normally protected from an application or user.

Sources

  • CVE.orgVulnerability recordCVE-2025-13918

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2025-13918

    30-day exploitation probability 0.16%

    first.org
  • EUVDVulnerability recordEUVD-2025-206455

    Symantec Endpoint Protection, prior to 14.3 RU10 Patch 1, RU9 Patch 2, and RU8 Patch 3, may be susceptible to a Elevation of Privilege vulnerability, which is a type of issue whereby an attacker may attempt to compromise the software application to gain elevated access to resourc

    euvd.enisa.europa.eu

References

Freshness

Last verified in this catalog Nov 3, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.

  • CVE.orgNov 4, 2026
  • FIRST EPSSNov 3, 2026
  • EUVDNov 2, 2026